Related Experiment Video
Updated: Jul 17, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
TGF-beta type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic
1Department of Pathology, Seoul National University College of Medicine, Chongno-gu, Seoul, Korea.
Abstract:
The role of transforming growth factor-beta (TGF-beta) receptor complex in the pathogenesis of crescentic glomerulonephritis (GN) is not clear. To test the hypothesis that TGF-beta signaling plays a crucial role in the development and progression of crescentic GN by inducing the activation of extracellular signal-regulated kinase (ERK) and expression of its target genes, anti-glomerular basement membrane (GBM) GN was induced in TGF-beta type II receptor (TGF-betaIIR) gene heterozygous (TGF-betaIIR(+/-)) C57BL/6J mice and wild-type animals. GN was initiated in preimmunized mice by administration of rabbit anti-mouse GBM serum. TGF-betaIIR deficiency was significantly associated with decreased renal damage at days 14, 21, and 28 after induction of GN: renal function impairment, proteinuria, proportion of crescents, glomerular accumulation of periodic acid-Schiff-positive material, relative cortical interstitial volume, as well as renal cortical phosphorylation of ERK and plasminogen activator inhibitor type I (PAI-1) and alpha2(I) collagen mRNA levels were significantly decreased in TGF-betaIIR(+/-) mice compared with wild-type animals. These results provide the first direct evidence that TGF-betaIIR deficiency protects against renal injury in crescentic GN, possibly by inhibiting the sustained activation of ERK and PAI-1 and alpha2(I) collagen gene expression. Thus, TGF-beta signaling appears to play an important role in the development and progression of crescentic GN by inducing the ERK activity, and PAI-1 and alpha2(I) mRNA expression.
Insights
Transforming growth factor-beta type II receptor (TGF-betaIIR) deficiency reduces kidney damage in crescentic glomerulonephritis. This suggests TGF-beta signaling is crucial for disease progression by activating ERK and related genes.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- The role of transforming growth factor-beta (TGF-beta) receptor complex in crescentic glomerulonephritis (GN) pathogenesis is unclear.
- TGF-beta signaling is implicated in kidney disease progression.
Purpose of the Study:
- To investigate if TGF-beta signaling is crucial in crescentic GN development and progression.
- To determine if TGF-beta signaling activates extracellular signal-regulated kinase (ERK) and its target genes in GN.
Main Methods:
- Induced anti-glomerular basement membrane (GBM) GN in TGF-beta type II receptor (TGF-betaIIR) heterozygous mice and wild-type controls.
- Assessed renal function, proteinuria, crescent formation, and interstitial volume.
- Measured ERK phosphorylation and expression of PAI-1 and alpha2(I) collagen mRNA.
Main Results:
- TGF-betaIIR deficiency significantly reduced renal damage, proteinuria, and crescent formation.
- Reduced glomerular and interstitial fibrosis markers were observed in deficient mice.
- Decreased renal cortical phosphorylation of ERK and reduced PAI-1 and alpha2(I) collagen mRNA levels were noted.
Conclusions:
- TGF-betaIIR deficiency protects against renal injury in experimental crescentic GN.
- TGF-beta signaling promotes crescentic GN progression by activating ERK and downstream gene expression.
- Targeting TGF-beta signaling may offer a therapeutic strategy for crescentic GN.
More Related Videos
06:39Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
TGF - β Signaling Pathway
GPCR Desensitization
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention